Blu is a prominent brand in the electronic cigarette market. Its development has involved strategic decisions by its owner, Fontem Ventures.
Brand Evolution and Regulatory Status
In 2016, Fontem Ventures discontinued its JAI e-cigarette brand to concentrate resources on strengthening the Blu brand. A significant regulatory development occurred on April 2, 2022, when the U.S. Food and Drug Administration (FDA) issued a Marketing Denial Order (MDO) to Fontem US for its myBlu pod vape device and multiple flavors of its refill pods.
Electronic Cigarette Composition and Considerations
The liquids used in electronic cigarettes, commonly known as e-liquids, typically contain Propylene Glycol (PG) and Vegetable Glycerin (VG). Studies on vaping generally regard both PG and VG as inert, meaning they are not likely to cause significant side effects. However, a small percentage of users may have allergies, sometimes leading to a preference for e-liquids with a higher VG concentration. VG itself is also sold as a skin softener.
Health Perspectives:
- Vaping products are recognized for containing substantially fewer harmful chemicals than traditional combustible cigarettes.
- They can be utilized as a potential aid for individuals seeking to quit smoking.
- The use of vape products may reduce the inhalation of tar and other detrimental chemicals typically found in cigarette smoke.
